Twist Bioscience (TWST) Non-Current Assets (2018 - 2026)

Twist Bioscience has reported Non-Current Assets over the past 9 years, most recently at $352.8 million for Q1 2026.

  • Quarterly Non-Current Assets rose 37.17% to $352.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Mar 2026, up 22.12% year-over-year, with the annual reading at $308.9 million for FY2025, 15.45% up from the prior year.
  • Non-Current Assets was $352.8 million for Q1 2026 at Twist Bioscience, up from $334.2 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $368.1 million in Q4 2022 and troughed at $257.2 million in Q1 2025.
  • The 5-year median for Non-Current Assets is $342.6 million (2023), against an average of $327.3 million.
  • Year-over-year, Non-Current Assets soared 415.6% in 2022 and then fell 24.26% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $368.1 million in 2022, then decreased by 6.93% to $342.6 million in 2023, then decreased by 23.15% to $263.3 million in 2024, then rose by 26.94% to $334.2 million in 2025, then rose by 5.56% to $352.8 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Non-Current Assets are $352.8 million (Q1 2026), $334.2 million (Q4 2025), and $308.9 million (Q3 2025).